AbbVie expands siRNA push with $335m ADARx deal

This marks AbbVie’s second major siRNA deal following its $1.4bn acquisition of Aliada Therapeutics in 2024.

May 16, 2025 - 06:00

AbbVie expands siRNA push with $335m ADARx deal

This marks AbbVie’s second major siRNA deal following its $1.4bn acquisition of Aliada Therapeutics in 2024.

Read the original article

Tags:

Previous Article

Engineering the future: how robotics and automation are transforming pharmaceuti...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Medicare advisers endorse reforms to lower drug spending

STAT+: Medicare advisers endorse reforms to lower drug ...

Apr 13, 2023

INV-347 by Inversago Pharma for Obesity: Likelihood of ...

Feb 20, 2024

Amgen scores Otezla patent win in court to keep competition at bay

Amgen scores Otezla patent win in court to keep competi...

Apr 20, 2023